PROMOTING ACCESS TO AFRICAN RESEARCH

Nigerian Journal of Health and Biomedical Sciences

Log in or Register to get access to full text downloads.

Remember me or Register



DOWNLOAD FULL TEXT Open Access  DOWNLOAD FULL TEXT Subscription or Fee Access

In vitro interaction of ampicillin with ciprofloxacin or spiramycin as determined by the decimal assay for additivity technique

CO Esimone, IR Iroha, OC Okeh, IG Ude, MU Adikwu

Abstract


The in vitro interactions of Ampicillin (AMP) with Ciprofloxacin (CIP) and Ampicillin with Spiramycin (SPIR) were evaluated against Staphylococcus aureus ATCC 12600 using the Decimal Assay for Additivity (DAA) technique. Most of the combinations of CIP/AMP with Biological Equivalent Factor (BEF) (5/30mg) or SPIR/AMP with biological equivalent factor (BEF) (10.96/30mg) against Staphylococcus aureus ATCC 12600 showed synergism. Given that the test organism was intrinsically resistant to either SPIR or AMP alone (MIC, 15.6 and 23.4 µg/ml respectively), the observed in vitro synergism could be therapeutically exploited. Moreover, the present data further authenticates the potential applicability of the DAA technique in selecting suitable antibiotic combinations prior to combined antimicrobial therapy.

Keywords: decimal assay for additivity (DAA), antibiotic interaction, Ciprofloxacin, spiramycin, ampicillin

Nigerian Journal of Health and Biomedical Sciences Vol. 5(1) 2006: 12-16



http://dx.doi.org/10.4314/njhbs.v5i1.11566
AJOL African Journals Online